NEO
Neogenomics Inc
Price:  
13.95 
USD
Volume:  
766,497.00
United States | Life Sciences Tools & Services
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

NEO WACC - Weighted Average Cost of Capital

The WACC of Neogenomics Inc (NEO) is 6.9%.

The Cost of Equity of Neogenomics Inc (NEO) is 7.80%.
The Cost of Debt of Neogenomics Inc (NEO) is 5.50%.

Range Selected
Cost of equity 6.20% - 9.40% 7.80%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 4.00% - 7.00% 5.50%
WACC 5.5% - 8.4% 6.9%
WACC

NEO WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.51 0.8
Additional risk adjustments 0.0% 0.5%
Cost of equity 6.20% 9.40%
Tax rate 26.20% 27.00%
Debt/Equity ratio 0.29 0.29
Cost of debt 4.00% 7.00%
After-tax WACC 5.5% 8.4%
Selected WACC 6.9%